I agree that this site is using cookies. You can find further informations here.
X
Gregorc, V
71  results:
Search for persons X
?
1

86P Artificial intelligence tools to predict early progress..:

Ogliari, F.R. ; Traverso, A. ; Barbieri, S....
ESMO Open.  9 (2024)  - p. 102665 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EP14.01-05 Neo-Adjuvant Immunotherapy in Malignant Pleural ..:

Novellis, P. ; Rossetti, F. ; Di Fonzo, R....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S713-S714 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Detection of pulmonary lesion during follow-up after surger..:

Cignoli, D.C. ; Bandiera, A. ; Fallara, G....
European Urology.  83 (2023)  - p. S495-S496 , 2023
Link: https://doi.org/10.1016/..
 
?
4

EP06.01-006 Multidisciplinary Team during the COVID-19 Pand..:

Ramella, S. ; Morabito, A. ; Silipigni, S....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S304 , 2022
Link: https://doi.org/10.1016/..
 
?
5

PO-1100 Impact of sarcopenia in oropharyngeal cancer patien..:

deantoni, C.L. ; Chiara, A. ; Mirabile, A....
Radiotherapy and Oncology.  170 (2022)  - p. S934-S935 , 2022
Link: https://doi.org/10.1016/..
 
?
6

EP05.01-024 Real-life Management of Stage III NSCLC Patient..:

Novello, S. ; Morabito, A. ; Silipigni, S....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S277-S278 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Eruptive cherry angiomas and uveal melanoma: beyond a simpl..:

Paolino, G. ; Cicinelli, M. V. ; Brianti, P....
Clinical and Experimental Dermatology.  46 (2021)  5 - p. 946-948 , 2021
Link: https://doi.org/10.1111/..
 
?
8

Real-world outcomes according to treatment strategies in AL..:

Gobbini, E. ; Chiari, R. ; Pizzutillo, P....
Clinical and Translational Oncology.  22 (2019)  3 - p. 294-301 , 2019
Link: https://doi.org/10.1007/..
 
?
9

3099 Phase 3 trial (NGR015) of best investigator choice (BI..:

Gregorc, V. ; Gaafar, R. ; Favaretto, A....
European Journal of Cancer.  51 (2015)  - p. S634 , 2015
Link: https://doi.org/10.1016/..
 
?
10

Associations Between ABCC2 Polymorphisms and Cisplatin Disp..:

Sprowl, J A ; Gregorc, V ; Lazzari, C...
Clinical Pharmacology & Therapeutics.  91 (2012)  6 - p. 1022-1026 , 2012
Link: https://doi.org/10.1038/..
 
?
11

9011 NGR-hTNF, a vascular targeting agent (VTA), in previou..:

Gregorc, V. ; Ceresoli, G.L. ; Zucali, P.A....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 509 , 2009
Link: https://doi.org/10.1016/..
 
?
12

6062 NGR-hTNF, a vascular targeting agent (VTA), administer..:

Rimassa, L. ; Santoro, A. ; Sobrero, A.F....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 340 , 2009
Link: https://doi.org/10.1016/..
 
?
13

1228 Phase I study of NGR-hTNF, a vascular targeting agent ..:

Citterio, G. ; De Braud, F.G. ; Gregorc, V....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 129 , 2009
Link: https://doi.org/10.1016/..
 
?
14

6617 Phase II study of NGR-hTNF, a selective vascular targe..:

Santoro, A. ; Citterio, G. ; Pressiani, T....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 395 , 2009
Link: https://doi.org/10.1016/..
 
?
15

Targeted delivery of TNF using NGR-TNF in combination with ..:

Giovannini, M. ; Gregorc, V. ; Viganò, M. G....
memo - Magazine of European Medical Oncology.  1 (2008)  1 - p. 43-46 , 2008
Link: https://doi.org/10.1007/..
 
1-15